Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian P Rubin

Showing results (101-110 of 258) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberansBrian P Rubin, Scott M Schuetze, Janet F Eary, et al.
Plos One|April 13, 2022
Aurintricarboxylic acid is a canonical disruptor of the TAZ-TEAD transcriptional complexKepeng Che, Ajaybabu V Pobbati, Caleb N Seavey, et al.
Clinical Orthopaedics and Related Research|October 28, 2020
Does PET/CT Aid in Detecting Primary Carcinoma in Patients with Skeletal Metastases of Unknown Primary?Joshua M Lawrenz, Jaymeson Gordon, Jaiben George, et al.
The American Journal of Case Reports|December 20, 2018
A Case of Undifferentiated Sarcoma in the Superior Vena Cava and Bilateral Cervical VeinsHiroshi Kobayashi, Yuka Kobayashi, Sho Yuasa, et al.
Cancer|December 4, 2004
Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapyScott M Schuetze, Brian P Rubin, Cheryl Vernon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2008
Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasmsJoshua Weaver, Erinn Downs-Kelly, John R Goldblum, et al.
American Journal of Clinical Pathology|October 22, 2015
Utility of BRAF V600E mutation-specific immunohistochemistry in detecting BRAF V600E-mutated gastrointestinal stromal tumorsDeepa T Patil, Shuang Ma, Mai Konishi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumorsSamuel Singer, Brian P Rubin, Marcia L Lux, et al.
Cancer Research|October 3, 2003
Absence of BRAF and NRAS mutations in uveal melanomaFrank Cruz, Brian P Rubin, David Wilson, et al.
Journal of Clinical Microbiology|September 5, 2020
A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic PatientsGary W Procop, Nabin K Shrestha, Sherilynn Vogel, et al.
Pageof 26

Showing results (101-110 of 258) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberansBrian P Rubin, Scott M Schuetze, Janet F Eary, et al.
Plos One|April 13, 2022
Aurintricarboxylic acid is a canonical disruptor of the TAZ-TEAD transcriptional complexKepeng Che, Ajaybabu V Pobbati, Caleb N Seavey, et al.
Clinical Orthopaedics and Related Research|October 28, 2020
Does PET/CT Aid in Detecting Primary Carcinoma in Patients with Skeletal Metastases of Unknown Primary?Joshua M Lawrenz, Jaymeson Gordon, Jaiben George, et al.
The American Journal of Case Reports|December 20, 2018
A Case of Undifferentiated Sarcoma in the Superior Vena Cava and Bilateral Cervical VeinsHiroshi Kobayashi, Yuka Kobayashi, Sho Yuasa, et al.
Cancer|December 4, 2004
Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapyScott M Schuetze, Brian P Rubin, Cheryl Vernon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2008
Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasmsJoshua Weaver, Erinn Downs-Kelly, John R Goldblum, et al.
American Journal of Clinical Pathology|October 22, 2015
Utility of BRAF V600E mutation-specific immunohistochemistry in detecting BRAF V600E-mutated gastrointestinal stromal tumorsDeepa T Patil, Shuang Ma, Mai Konishi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumorsSamuel Singer, Brian P Rubin, Marcia L Lux, et al.
Cancer Research|October 3, 2003
Absence of BRAF and NRAS mutations in uveal melanomaFrank Cruz, Brian P Rubin, David Wilson, et al.
Journal of Clinical Microbiology|September 5, 2020
A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic PatientsGary W Procop, Nabin K Shrestha, Sherilynn Vogel, et al.
Pageof 26